Answers are grounded in this paper and cite their sources.
Background Background parenchymal enhancement (BPE) can obscure breast cancers in contrast-enhanced imaging. We compared BPE, lesion contrast, and lesion-size estimates on prone photon-counting CT (PC-CT) compared with breast MRI. Methods This retrospective single-center study included patients with biopsy-proven breast cancer who underwent same-day prone contrast-enhanced PC-CT and breast MRI. PC-CT reconstructions comprised iodine maps and monoenergetic post-contrast images. Malignant lesion contrast-to-noise ratios (CNRs), diameters, BPE characteristics, T-category, and ductal carcinoma in situ (DCIS) suspicion were assessed. Interreader reliability was evaluated using weighted Cohen's kappa. Results Thirty-two patients were included (mean age 53 ± 14 years). Tumor-to-parenchyma CNR was numerically higher on MRI (p = 0.138) and tumor-to-fat CNR on PC-CT (p = 0.165), without significant differences. MRI yielded larger long-axis tumor diameters than PC-CT (31.3 ± 21.4 mm versus 29.5 ± 21.2 mm, p = 0.005), whereas short-axis diameter did not differ (p = 0.420). Five of 31 lesions (16%) shifted by one adjacent size category, MRI assigned a larger category in four cases. Imaging-based T-category was identical between modalities for both readers. Median BPE intensity was significantly lower on PC-CT iodine maps than on MRI for both readers (R1: 1 [IQR 1–2], R2: 1 [IQR 1–2] vs. R1: 2 [1–3], R2: 2 [2–3]; p < 0.001). Interreader agreement was substantial for BPE intensity on PC-CT iodine maps (κ = 0.669) and MRI (κ = 0.773) and almost perfect for DCIS-suspicion ratings ( κ = 0.851) . Both readers considered BPE to be best depicted on iodine maps in 32/32 cases. Conclusions In this small retrospective cohort, prone contrast-enhanced PC-CT showed lower BPE than MRI, while lesion contrast remained comparable. MRI yielded larger long-axis measurements, while imaging-based T-category remained identical. DCIS related observations remain exploratory and require validation.
No takes yet. Share an insight, caveat, or question.
Wilpert et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: